Skip to main content
Howard Weiner, MD, Allergy & Immunology, Boca Raton, FL

HowardMWeinerMDMPH

Allergy & Immunology • Boca Raton, FL

Asthma & Allergic Conditions

Medical Assessment Institute Inc

Join to view full profile

Dr. Weiner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Weiner's full profile

Already have an account?

  • Office

    2385 NW Executive Center Dr
    Suite 102
    Boca Raton, FL 33431
    Phone+1 561-451-0200
    Fax+1 561-451-0700

Education & Training

  • Medical College of Wisconsin
    Medical College of WisconsinMasters of Public Health, Industrial Hygiene and Toxicology, 1991 - 1994
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Allergy and Immunology, 1974 - 1976
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1971 - 1974
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1971

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1988 - 2025
  • NJ State Medical License
    NJ State Medical License 1976 - 2003
  • PA State Medical License
    PA State Medical License 1972 - 2002
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Occupational Medicine
    American Board of Preventive Medicine Occupational Medicine

Awards, Honors, & Recognition

  • Top Doctors: Florida Castle Connolly, 2000

Publications & Presentations

PubMed

Press Mentions

  • Will We Ever Cure Cruel Alzheimer’s?
    Will We Ever Cure Cruel Alzheimer’s?July 7th, 2022
  • Tiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers
    Tiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy VolunteersSeptember 16th, 2019
  • Tiziana Life Sciences PLC: Tiziana Life Sciences PLC Announces Development Plans for Foralumab & SAB Appointments
    Tiziana Life Sciences PLC: Tiziana Life Sciences PLC Announces Development Plans for Foralumab & SAB AppointmentsFebruary 10th, 2016

Dr. Howard Weiner, Dr. Howard Weiner, MD, Dr. H Weiner, Dr. Howard M Weiner